The company develops and produces non-vascular interventional stent technology for hospitals, physicians, and patients to create artificial pathways and support structures for hollow lumen organs that are obstructed by cancerous lesions or benign disease. In addition, Alveolus offers pulmonary, gastrointestinal, and ancillary products for interventional pulmonologists, gastroenterologists, and interventional radiologists to use in the lungs, esophagus, enteral, and biliary areas.